Escalon Medical Corp.
ESMC · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,675,321 | $2,570 | $3,474 | $3,221 |
| % Growth | 103,995.9% | -26% | 7.9% | – |
| Cost of Goods Sold | $1,554,579 | $1,446 | $1,874 | $1,647 |
| Gross Profit | $1,120,742 | $1,124 | $1,600 | $1,574 |
| % Margin | 41.9% | 43.7% | 46.1% | 48.9% |
| R&D Expenses | $216,098 | $292 | $165 | $156 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,107,395 | $1,204 | $1,159 | $1,162 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,323,493 | $1,496 | $1,324 | $1,318 |
| Operating Income | -$202,751 | -$372 | $276 | $256 |
| % Margin | -7.6% | -14.5% | 7.9% | 7.9% |
| Other Income/Exp. Net | -$37,101 | -$8 | -$5 | -$10 |
| Pre-Tax Income | -$239,852 | -$380 | $271 | $246 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$239,852 | -$380 | $271 | $246 |
| % Margin | -9% | -14.8% | 7.8% | 7.6% |
| EPS | -0.03 | -0.028 | 0.018 | 0.02 |
| % Growth | -8.3% | -251.4% | -8.5% | – |
| EPS Diluted | -0.03 | -0.028 | 0.018 | 0.02 |
| Weighted Avg Shares Out | 7,415 | 7,415 | 7,415 | 7,415 |
| Weighted Avg Shares Out Dil | 7,415 | 7,415 | 14,166 | 14,082 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4,304 | $8 | $5 | $5 |
| Depreciation & Amortization | $8,170 | $9 | $9 | $10 |
| EBITDA | -$227,378 | -$363 | $285 | $261 |
| % Margin | -8.5% | -14.1% | 8.2% | 8.1% |